Ann: MedAdvisor FY19 Annual Report & Appendix 4E, page-2

  1. 316 Posts.
    lightbulb Created with Sketch. 66
    This has to be a joke? How is the valuation of this business even justified? Loss as exploded by a further 100%. Revenue growth is pathetic. Consumer user numbers are a joke. And they are expanding offshore because it has been so successful in Australia? Well no, it hasn't. But hey, let's reward management with more share options at a zero strike price? I honestly fail to understand how this company can carry a value north of $10m on these numbers and performance. IMO the board are delusional. I keep watching this stock thinking there might be something here but for the life of me can't find a reason to invest.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
7.8¢
Change
-0.002(2.50%)
Mkt cap ! $48.73M
Open High Low Value Volume
8.0¢ 8.0¢ 7.8¢ $15.10K 193.2K

Buyers (Bids)

No. Vol. Price($)
3 25695 7.8¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 45937 1
View Market Depth
Last trade - 10.45am 18/06/2025 (20 minute delay) ?
MDR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.